Tom Dorsett, founder and CEO of ePatientFinder, courtesy photo.

Tom Dorsett, founder and CEO of ePatientFinder, courtesy photo.

ePatientFinder, a matchmaking platform for physicians, patients and clinical trials, announced this week it has received $8.2 million in venture capital.

The Austin-based startup has raised a total of $11 million since its founding in 2013. Tom Dorsett, Tushar Jain, Greg Sweatt and Dillon Krug co-founded the company. Silicon Hills News did this profile on ePatientFinder last year.

ePatientFinder did not reveal the names of its latest investors, but it reported the funds came from a strategic healthcare technology investment syndicate.

The company plans to use the new funds to “fuel the company’s next stage of growth,” according to a news release.

Its platform works with drug makers, medical device and research organizations to connect them with physicians to identify and refer patients that might make good candidates to paritipate in a clinical trial. The U.S. Food and Drug Administration requires different stages of testing before a drug or device can be approved for sale. One of those stages involves testing the drug or device on humans in clinical trials.

The ePatientFinder platform seeks to match the best qualified patients with the latest drugs and devices being tested in clinical trials.

“The successful closing of this round of funding underscores ePatientFinder’s leadership role in solving the clinical trials recruitment challenge by leveraging the trusted physician-patient relationship and EHR data,” ePatientFinder CEO Dorsett said in a news release. “Our partners and investors share our vision to address inefficiency in the clinical trial recruitment process through the use of technology-enabled solutions. The additional financing will allow us to further expand patient access to available treatment options through our platform.”

ePatientFinder notifies physicians “when a new trial becomes available in their area; the platform uses sophisticated algorithms and an innovative three-tier filtering process to help physicians identify potential participants,” according to the release.